Yang, Shenmiao http://orcid.org/0000-0001-7261-8449
Kay, Neil E. http://orcid.org/0000-0002-5951-5055
Shi, Min http://orcid.org/0000-0002-5741-4293
Hanson, Curtis A.
Gale, Robert Peter http://orcid.org/0000-0002-9156-1676
Article History
Received: 11 August 2022
Revised: 31 August 2022
Accepted: 2 September 2022
First Online: 13 September 2022
Conflict of interest
: NEK, Advisory Board for: AbbVie, Astra Zeneca, Beigene, Behring, Cytomx Therapy, Dava Oncology, Janssen, Juno Therapeutics, Oncotracker, Pharmacyclics and Targeted Oncology. DSMC (Data Safety Monitoring Committee) for: Agios Pharm, AstraZeneca, BMS –Celgene, Cytomx Therapeutics, Dren Bio Janssen, Morpho-sys, Rigel. Research funding from: AbbVie, Acerta Pharma, Bristol Meyer Squib, Celgene, Genentech, MEI Pharma, Pharmacyclics, Sunesis, TG Therapeutics, Tolero Pharmaceuticals. RPG, consultant to NexImmune Inc, Nanexa Pharma, Ascentage Pharma Group, Antengene Biotech LLC, Medical Director, FFF Enterprises Inc.; Partner, AZAC Inc.; Board of Directors, Russian Foundation for Cancer Research Support; and Scientific Advisory Board: StemRad Ltd.